Showing results (311-320 of 552) with videos related to
Sort By:
Pageof 56
Annals of Clinical and Laboratory Science|February 10, 2009
IgE anti-varicella zoster virus and other immune responses before, during, and after shinglesTamar A Smith-Norowitz, Joby Josekutty, Hadar Lev-Tov, et al.The Journal of Allergy and Clinical Immunology. in Practice|December 12, 2018
Health Utility Scores of Atopic Dermatitis in US AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2019
Atopic Dermatitis in US Adults: From Population to Health Care UtilizationJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.International Journal of Biomedical Science : IJBS|May 16, 2013
Long Term Persistence of IgE Anti-Varicella Zoster Virus in Pediatric and Adult Serum Post Chicken Pox Infection and after Vaccination with Varicella Virus VaccineTamar A Smith-Norowitz, Joby Josekutty, Jonathan I Silverberg, et al.Journal of the American Academy of Dermatology|February 10, 2024
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a studyJonathan I Silverberg, Robert S Kirsner, David J Margolis, et al.Journal of Drugs in Dermatology : JDD|October 6, 2023
Selection of Nemolizumab Clinical Dosage for Atopic DermatitisNathalie Wagner, Luca Loprete, Vincent Duval, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2022
Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7Jonathan I Silverberg, Eric L Simpson, Jacob Pontoppidan Thyssen, et al.Journal of Drugs in Dermatology : JDD|October 7, 2020
Clinical Relevance of Skin Pain in Atopic DermatitisSonja Ständer, Eric L Simpson, Emma Guttman-Yassky, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2022
Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tabletsRichard B Warren, Bruce Strober, Jonathan I Silverberg, et al.JAMA Dermatology|June 4, 2020
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical TrialJonathan I Silverberg, Eric L Simpson, Jacob P Thyssen, et al.Pageof 56